Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Yimmugo by Biotest for Primary Immune Deficiency (PID): Likelihood of Approval
Yimmugo is under clinical development by Biotest and currently in Phase III for Primary Immune Deficiency (PID). According to GlobalData,...